Serum Lp-PLA2 Level Predicting Coronary Artery Lesions in Children with Kawasaki Disease

Xiong Zhang1, Ya-Wang Shao2, Ya-Lan Zhang3

  • 1Department of Laboratory, First People's Hospital of Xianyang City, Xianyang, Shaanxi Province, China. 15191018996@163.com.

The Heart Surgery Forum
|September 2, 2021
PubMed

Insights

Lipoprotein-associated phospholipase A2 (Lp-PLA2) levels are elevated in children with Kawasaki disease (KD) and correlate with coronary artery lesions. Lp-PLA2 may aid in KD diagnosis and assessing coronary artery damage.

Area of Science:

  • Pediatric Cardiology
  • Inflammatory Diseases
  • Biomarker Discovery

Background:

  • Kawasaki disease (KD) is a critical pediatric inflammatory condition.
  • Coronary vasculitis and subsequent coronary artery lesions (CAL) are significant complications of KD.
  • The role of Lipoprotein-associated phospholipase A2 (Lp-PLA2) in KD pathogenesis requires further investigation.

Purpose of the Study:

  • To investigate the association between serum Lp-PLA2 levels and the presence and severity of coronary artery lesions (CAL) in children diagnosed with Kawasaki disease (KD).
  • To evaluate Lp-PLA2 as a potential diagnostic and prognostic biomarker for KD, particularly concerning cardiovascular complications.

Main Methods:

  • Serum levels of Lp-PLA2, Interferon-γ (IFN-γ), Interleukin-6 (IL-6), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) were measured in 93 KD patients and 42 controls.
  • Echocardiography and color Doppler ultrasound were used to assess coronary artery diameters (LMCA, LADC, PRCA) and carotid intima-media thickness (IMT).
  • Statistical analyses, including logistic regression, were performed to determine the correlation between biomarkers and CAL.

Main Results:

  • KD patients exhibited significantly elevated levels of WBC, ESR, CRP, IFN-γ, IL-6, Lp-PLA2, and IMT compared to controls.
  • Children with CAL showed markedly higher levels of CRP, IFN-γ, IL-6, Lp-PLA2, and IMT than those with normal coronary arteries (NCA).
  • Elevated Lp-PLA2 levels were independently associated with KD and CAL, positively correlating with inflammatory markers and coronary artery diameters.

Conclusions:

  • Lp-PLA2 is implicated in the pathological mechanisms underlying Kawasaki disease.
  • Serum Lp-PLA2 levels serve as a valuable indicator for diagnosing KD and assessing the extent of coronary artery lesions in affected children.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
164
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
128
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
267
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
48
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
96
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
73